# Cord Blood Transplant in Adults With Blood Cancers

> **NCT05884333** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 54 (estimated)

## Conditions studied

- Acute Myelogenous Leukemia (AML)
- Acute Lymphoblastic Leukemia (ALL)
- Chronic Myelogenous Leukemia (CML)
- Myelodysplastic Syndromes (MDS)
- Myeloproliferative Disorder
- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Conditioning Chemotherapy
- **BIOLOGICAL:** Cord blood graft

## Key facts

- **NCT ID:** NCT05884333
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-22
- **Primary completion:** 2028-05-22
- **Final completion:** 2028-05-22
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05884333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05884333, "Cord Blood Transplant in Adults With Blood Cancers". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT05884333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*